Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled <scp>multi‐centre</scp> clinical trial-Reference-Cited by-同舟云学术

Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi‐centre clinical trial

Published:2022-01-09 Issue:5 Volume:19 Page:1197-1209
ISSN:1742-4801
Container-title:International Wound Journal
language:en
Short-container-title:International Wound Journal

Author:

Armstrong David G.¹^ORCID,Orgill Dennis P.²^ORCID,Galiano Robert D.³^ORCID,Glat Paul M.⁴^ORCID,Kaufman Jarrod P.⁵^ORCID,Carter Marissa J.⁶^ORCID,DiDomenico Lawrence A.⁷,Zelen Charles M.²^ORCID

Affiliation:

1. Division of Surgery, Keck School of Medicine University of Southern California Los Angeles California USA

2. Professional Education and Research Institute Roanoke Virginia USA

3. Division of Plastic Surgery, Feinberg School of Medicine Northwestern University Chicago Illinois USA

4. Surgery and Pediatrics Drexel University College of Medicine, St. Christopher's Hospital for Children Philadelphia Pennsylvania USA

5. Department of Surgery, Temple University School of Medicine and McGowan Institute for Regenerative Medicine University of Pittsburgh Pittsburgh Pennsylvania USA

6. Strategic Solutions, Inc. Bozeman Montana USA

7. Lower Extremity Institute for Research and Therapy Youngstown Ohio USA

Funder

Geistlich Pharma

Publisher

Wiley

Subject

Dermatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iwj.13715

Reference37 articles.

1. National Diabetes Statistics Report 2020. Centers for Disease Control and Prevention; 2020.